Mosaic Family Wealth’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-286
Closed -$12K – 616
2019
Q1
$12K Hold
286
– – ﹤0.01% 483
2018
Q4
$10K Hold
286
– – ﹤0.01% 490
2018
Q3
$13K Hold
286
– – 0.01% 480
2018
Q2
$12K Hold
286
– – ﹤0.01% 517
2018
Q1
$12K Hold
286
– – ﹤0.01% 508
2017
Q4
$12K Hold
286
– – ﹤0.01% 512
2017
Q3
$12K Hold
286
– – ﹤0.01% 553
2017
Q2
$12K Hold
286
– – 0.01% 489
2017
Q1
$12K Hold
286
– – 0.01% 499
2016
Q4
$11K Hold
286
– – 0.01% 490
2016
Q3
$13K Sell
286
-1
-0.3% -$45 0.01% 490
2016
Q2
$12K Buy
287
+1
+0.3% +$42 0.01% 512
2016
Q1
$11K Hold
286
– – 0.01% 521
2015
Q4
$14K Buy
+286
New +$14.6K 0.01% 492

Other funds holding XPH

Mosaic Family Wealth's XPH Position: Q2 2019 in Review

Mosaic Family Wealth sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2019, closing a stake of 286 shares — an estimated $12K sold.

Mosaic Family Wealth first reported a position in XPH in Q4 2015 and held it in 14 quarters. The position peaked at $14K in Q4 2015. 61 funds tracked by Wall St. Rank hold XPH as of Q2 2019.

  • Mosaic Family Wealth reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
  • Mosaic Family Wealth sold 286 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2019, an estimated $12K.
  • Mosaic Family Wealth first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 14 quarters.
  • Mosaic Family Wealth's State Street SPDR S&P Pharmaceuticals ETF position peaked at $14K in Q4 2015.
  • 61 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2019.

Based on Mosaic Family Wealth's 13F filing for Q2 2019, filed 12 Aug 2019.